VivoSeq
Other

Simethicone

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Simethicone is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed8 · 67%
Unknown status3 · 25%
Active, not recruiting1 · 8%

Trial Activity

12 trials

Small Volume Simethicone Before Gastroscopy: Any Benefit?
Completed··Phase 2/3·NCT02555228·54 enrolled
Effect of Simethicone on Reducing Bowel Interference During Tubal Resection
Completed··Phase 3·NCT03429621·120 enrolled
Does Simethicone Improve Operative Field in Gynecological Operations
Unknown status··Phase 3·NCT03009604·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)